Codiak BioSciences, Inc. Deferred Tax Assets, in Process Research and Development

Codiak BioSciences, Inc. Deferred Tax Assets, in Process Research and Development

Codiak BioSciences, Inc. had Deferred Tax Assets, in Process Research and Development of $7.79 million as of 2021-12-31, per its 10-K filed 2022-03-10.

Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross

us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment · last filed 2022-03-10

• 2021-12-31: Deferred Tax Assets, in Process Research and Development $7.79M.
• 2020-12-31: Deferred Tax Assets, in Process Research and Development $8.39M.
• 2019-12-31: Deferred Tax Assets, in Process Research and Development $3.93M.